OncoSec Medical to Present at Prominent Scientific and Investment Conferences in March

OncoSec Medical Inc. , a company developing DNA-based intratumoral cancer immunotherapies, announced today that it will present at several high-profile events in March



from Content Keyword RSS http://ift.tt/1EfLFFx

via IFTTT